CRNX
Price
$53.25
Change
+$0.01 (+0.02%)
Updated
Jan 9, 04:59 PM (EDT)
Capitalization
5.46B
54 days until earnings call
Intraday BUY SELL Signals
TRDA
Price
$10.03
Change
-$0.50 (-4.75%)
Updated
Jan 9, 04:59 PM (EDT)
Capitalization
402.07M
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRNX vs TRDA

Header iconCRNX vs TRDA Comparison
Open Charts CRNX vs TRDABanner chart's image
Crinetics Pharmaceuticals
Price$53.25
Change+$0.01 (+0.02%)
Volume$14.92K
Capitalization5.46B
Entrada Therapeutics
Price$10.03
Change-$0.50 (-4.75%)
Volume$4.3K
Capitalization402.07M
CRNX vs TRDA Comparison Chart in %
CRNX
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRNX vs. TRDA commentary
Jan 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and TRDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 10, 2026
Stock price -- (CRNX: $53.24 vs. TRDA: $10.52)
Brand notoriety: CRNX and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 159% vs. TRDA: 58%
Market capitalization -- CRNX: $5.46B vs. TRDA: $402.07M
CRNX [@Biotechnology] is valued at $5.46B. TRDA’s [@Biotechnology] market capitalization is $402.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.17B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, CRNX is a better buy in the long-term than TRDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 4 TA indicator(s) are bullish while TRDA’s TA Score has 3 bullish TA indicator(s).

  • CRNX’s TA Score: 4 bullish, 4 bearish.
  • TRDA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than TRDA.

Price Growth

CRNX (@Biotechnology) experienced а +14.37% price change this week, while TRDA (@Biotechnology) price change was +2.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.49%. For the same industry, the average monthly price growth was -0.45%, and the average quarterly price growth was +47.36%.

Reported Earning Dates

CRNX is expected to report earnings on Mar 04, 2026.

TRDA is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+3.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($5.46B) has a higher market cap than TRDA($402M). CRNX YTD gains are higher at: 14.372 vs. TRDA (2.335). TRDA has higher annual earnings (EBITDA): -117.36M vs. CRNX (-474.16M). CRNX has more cash in the bank: 1.09B vs. TRDA (327M). CRNX has less debt than TRDA: CRNX (49.1M) vs TRDA (52.4M). TRDA has higher revenues than CRNX: TRDA (61.5M) vs CRNX (1.54M).
CRNXTRDACRNX / TRDA
Capitalization5.46B402M1,358%
EBITDA-474.16M-117.36M404%
Gain YTD14.3722.335616%
P/E RatioN/A10.26-
Revenue1.54M61.5M2%
Total Cash1.09B327M334%
Total Debt49.1M52.4M94%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
42
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXTRDA
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
74%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
76%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVADX63.871.07
+1.70%
Franklin Small Cap Value Adv
SAREX11.060.11
+1.00%
SA Real Estate Securities
LZIEX19.260.02
+0.10%
Lazard International Equity Instl
FIDEX14.98N/A
N/A
Fidelity SAI Sustainable U.S. Equity Fd
AMPFX46.17-0.17
-0.37%
American Funds AMCAP F1

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-0.19%
XNCR - CRNX
59%
Loosely correlated
-5.08%
RVMD - CRNX
52%
Loosely correlated
+4.56%
NUVL - CRNX
52%
Loosely correlated
-3.89%
IDYA - CRNX
52%
Loosely correlated
-3.78%
CLDX - CRNX
51%
Loosely correlated
-1.48%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with NRIX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-2.14%
NRIX - TRDA
51%
Loosely correlated
+0.76%
IDYA - TRDA
48%
Loosely correlated
-3.78%
CRNX - TRDA
47%
Loosely correlated
-0.19%
SYRE - TRDA
47%
Loosely correlated
-2.93%
VYGR - TRDA
47%
Loosely correlated
-0.73%
More